Pregled bibliografske jedinice broj: 907804
Predicting of biological targets and admet properties of synthesized hydroxyurea derivatives
Predicting of biological targets and admet properties of synthesized hydroxyurea derivatives // 6th Pharmaceutical Sciences World Congress (PSWC), FIP Congress in Stockholm 2017, Online Abstracts (https://www.fip.org/abstracts?page=abstracts&action=item&item=18067)
Stockholm: International Pharmaceutical Federation (FIP), 2017. PSWC-18067, 1 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 907804 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Predicting of biological targets and admet properties of synthesized hydroxyurea derivatives
Autori
Jadrijević-Mladar Takač, Milena ; Takač, Vedran
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
6th Pharmaceutical Sciences World Congress (PSWC), FIP Congress in Stockholm 2017, Online Abstracts (https://www.fip.org/abstracts?page=abstracts&action=item&item=18067)
/ - Stockholm : International Pharmaceutical Federation (FIP), 2017
Skup
6th Pharmaceutical Sciences World Congress 2017, Future Medicines For One World - Systems approaches to drug discovery, development and clinical usage
Mjesto i datum
Stockholm, Švedska, 21.05.2017. - 24.05.2017
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Hydroxyureas ; on- and off- target prediction ; ADMET ; Safety profile
(hydroxyureas ; on- and off- target prediction, ADMET ; safety profile)
Sažetak
Backgrounds. A diverse cyclic and acyclic hydroxyurea derivatives were synthesized and tested on different biological acivities, i.e., the cell viability on human acute monocytic leukemia THP-1 and human acute T cell leukemia Jurkat cell lines, as well as on antibacterial activity against three E. coli strains, i.e., a strain susceptible to antibiotics, a strain resistant to macrolide antibiotics and a strain resistant to aminoglycoside antibiotics. Aims. The aim of this study is to evaluate the potential biological targets and to predict ADMET properties of investigated hydroxyurea derivatives in order to get more insights in their pharmacological and safety profile. Methods. Potential biological targets were evaluated using Swiss Target Prediction (www.swisstargetprediction.ch) while ADMET properties were computed using ADMET PredictorTM 8.0 (Simulations Plus, USA). Results. The results of biological targets evaluation of the most active compounds revealed: the muscleblind-like protein 1, 2 and 3 as potentional targets of N1-benzyloxy- N2-p-(carboxylic acid)phenyl urea (6), the P2X purinoceptor 1 with poor probability of N1-hydroxy-N2-p-(carboxylic acid)phenyl urea (12), different carbonic anhydrases (1-7) of N1, N2, N3-trihydroxybiuret (14) and the fatty-acid amide hydrolase 1 of 1-(N-benzyloxycarbamoyl)benzotriazole (1). These molecules are either CYP 2E1 and CYP 1A2 substrates or CYP 1A2 inhibitors. ADMET Predictor analysis predicted ADMET risk between 1 to 7, CYP risk between 0 to 2 and TOX risk between 1 to 5. Summary/Conclusion. A variety of biological targets of investigated hydroxyurea derivatives as well as predicted ADMET properties have indicated on a high toxic potential of these compounds.
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb
Profili:
Milena Jadrijević-Mladar Takač
(autor)